To prevent future administrations from revoking a policy aimed at promoting insulin competition, Reps. Diana DeGette (D-Colo.) and Tom Reed (R-N.Y.) introduced a bill Monday that would make into law new FDA guidelines that will bring interchangeable insulin products to the U.S. market.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,